Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients.
Polo样激酶1作为生物标志物,可预测乳腺浸润性癌患者的预后和免疫治疗
期刊:Oncology Research
影响因子:4.1
doi:10.32604/or.2023.030887
Shen Juan, Zhang Weiyu, Jin Qinqin, Gong Fuyu, Zhang Heping, Xu Hongliang, Li Jiejie, Yao Hui, Jiang Xiya, Yang Yinting, Hong Lin, Mei Jie, Song Yang, Zhou Shuguang